The Clinical and Molecular Characteristics of FLT3 Mutations in Chinese De Novo Adolescent and Adult Acute Lymphoblastic Leukemia Patients.

[1]  O. Abdel-Wahab,et al.  Comprehensive mutational profiling of core binding factor acute myeloid leukemia. , 2016, Blood.

[2]  M. Konopleva,et al.  Early T-cell precursor acute lymphoblastic leukemia/lymphoma (ETP-ALL/LBL) in adolescents and adults: a high-risk subtype. , 2016, Blood.

[3]  W. Hiddemann,et al.  Activating FLT3 Mutants Show Distinct Gain-of-Function Phenotypes In Vitro and a Characteristic Signaling Pathway Profile Associated with Prognosis in Acute Myeloid Leukemia , 2014, PloS one.

[4]  D. Huso,et al.  FLT3/D835Y mutation knock-in mice display less aggressive disease compared with FLT3/internal tandem duplication (ITD) mice , 2013, Proceedings of the National Academy of Sciences.

[5]  E. Thiel,et al.  FLT3 Mutations in Early T-Cell Precursor ALL Characterize a Stem Cell Like Leukemia and Imply the Clinical Use of Tyrosine Kinase Inhibitors , 2013, PloS one.

[6]  L. Rönnstrand,et al.  FLT3 mutations in patients with childhood acute lymphoblastic leukemia (ALL) , 2013, Medical Oncology.

[7]  L. Medeiros,et al.  CD117 expression is a sensitive but nonspecific predictor of FLT3 mutation in T acute lymphoblastic leukemia and T/myeloid acute leukemia. , 2012, American journal of clinical pathology.

[8]  E. Thiel,et al.  Clinical and molecular characterization of early T-cell precursor leukemia: a high-risk subgroup in adult T-ALL with a high frequency of FLT3 mutations , 2012, Blood Cancer Journal.

[9]  E. Thiel,et al.  High Rate of FLT3 Mutations In Adult ETP-ALL. , 2010 .

[10]  G. Lin,et al.  Prevalence and Prognostic Significance of FLT3 Gene Mutations in Patients with Acute Leukaemia: Analysis of Patients from the Shanghai Leukaemia Co-operative Group , 2010, The Journal of international medical research.

[11]  Kristina Masson,et al.  Oncogenic signaling from the hematopoietic growth factor receptors c-Kit and Flt3. , 2009, Cellular signalling.

[12]  G. Holländer,et al.  Flt3 ligand–receptor interaction is important for maintenance of early thymic progenitor numbers in steady‐state thymopoiesis , 2009, European journal of immunology.

[13]  Cheng Cheng,et al.  Early T-cell precursor leukaemia: a subtype of very high-risk acute lymphoblastic leukaemia. , 2009, The Lancet. Oncology.

[14]  F. Ginhoux,et al.  FMS-like tyrosine kinase 3 is required for dendritic cell development in peripheral lymphoid tissues , 2008, Nature Immunology.

[15]  T. Ikawa,et al.  Adult T-cell progenitors retain myeloid potential , 2008, Nature.

[16]  T. Haferlach,et al.  Prognostic relevance of FLT3-TKD mutations in AML: the combination matters--an analysis of 3082 patients. , 2008, Blood.

[17]  M. Slovak,et al.  Impact of cytogenetics on the outcome of adult acute lymphoblastic leukemia: results of Southwest Oncology Group 9400 study. , 2008, Blood.

[18]  A. Mead,et al.  FLT3 tyrosine kinase domain mutations are biologically distinct from and have a significantly more favorable prognosis than FLT3 internal tandem duplications in patients with acute myeloid leukemia. , 2007, Blood.

[19]  M. Tallman,et al.  Induction therapy for adults with acute lymphoblastic leukemia: results of more than 1500 patients from the international ALL trial: MRC UKALL XII/ECOG E2993. , 2005, Blood.

[20]  D. Fabbro,et al.  FLT3 internal tandem duplication mutations induce myeloproliferative or lymphoid disease in a transgenic mouse model , 2005, Oncogene.

[21]  H. Kantarjian,et al.  Adult acute lymphoblastic leukemia. , 2005, Mayo Clinic proceedings.

[22]  C. Miething,et al.  FLT3-ITD and tyrosine kinase domain mutants induce 2 distinct phenotypes in a murine bone marrow transplantation model. , 2005, Blood.

[23]  J. Aster,et al.  Notch signaling controls the generation and differentiation of early T lineage progenitors , 2005, Nature Immunology.

[24]  K. Sakamoto,et al.  Topics in pediatric leukemia--acute lymphoblastic leukemia. , 2005, MedGenMed : Medscape general medicine.

[25]  A. Ferrando,et al.  Activating FLT3 mutations in CD117/KIT(+) T-cell acute lymphoblastic leukemias. , 2004, Blood.

[26]  G. Basso,et al.  CD99 expression in T-lineage ALL: implications for flow cytometric detection of minimal residual disease , 2004, Leukemia.

[27]  J. Radich,et al.  The role of FLT3 in haematopoietic malignancies , 2003, Nature Reviews Cancer.

[28]  L. Shih,et al.  Internal tandem duplication of FLT3 in relapsed acute myeloid leukemia: a comparative analysis of bone marrow samples from 108 adult patients at diagnosis and relapse. , 2002, Blood.

[29]  J. Griffin,et al.  The roles of FLT3 in hematopoiesis and leukemia. , 2002, Blood.

[30]  Martin Dugas,et al.  Analysis of FLT3 length mutations in 1003 patients with acute myeloid leukemia: correlation to cytogenetics, FAB subtype, and prognosis in the AMLCG study and usefulness as a marker for the detection of minimal residual disease. , 2002 .

[31]  A. Baruchel,et al.  Prognostic study of continuous variables (white blood cell count, peripheral blast cell count, haemoglobin level, platelet count and age) in childhood acute lymphoblastic leukaemia. Analysis of a population of 1545 children treated by the French Acute Lymphoblastic Leukaemia Group (FRALLE) , 2000, British Journal of Cancer.

[32]  J. Reilly,et al.  FLT3 internal tandem duplication mutations in adult acute myeloid leukaemia define a high-risk group. , 2000 .

[33]  J. Aigueperse,et al.  CD135 (Flk2/Flt3) Expression by Human Thymocytes Delineates a Possible Role of FLT3‐Ligand in T‐Cell Precursor Proliferation and Differentiation , 2000, Scandinavian journal of immunology.

[34]  D. Birnbaum,et al.  Human FLT3/FLK2 receptor tyrosine kinase is expressed at the surface of normal and malignant hematopoietic cells. , 1996, Leukemia.

[35]  S. Goff,et al.  Targeted disruption of the flk2/flt3 gene leads to deficiencies in primitive hematopoietic progenitors. , 1995, Immunity.

[36]  P. Ambros,et al.  Flow cytometric assessment of human MIC2 expression in bone marrow, thymus, and peripheral blood. , 1994, Blood.

[37]  A. Cherry,et al.  Karyotype is an independent prognostic factor in adult acute lymphoblastic leukemia (ALL): analysis of cytogenetic data from patients treated on the Medical Research Council (MRC) UKALLXII/Eastern Cooperative Oncology Group (ECOG) 2993 trial. , 2005, Blood.

[38]  P. Bolufer,et al.  Incidence and prognostic value of FLT3 internal tandem duplication and D835 mutations in acute myeloid leukemia. , 2003, Haematologica.

[39]  D. Gilliland,et al.  FLT3 internal tandem duplication mutations associated with human acute myeloid leukemias induce myeloproliferative disease in a murine bone marrow transplant model. , 2002, Blood.

[40]  I. Bernstein,et al.  Prevalence and prognostic significance of Flt3 internal tandem duplication in pediatric acute myeloid leukemia. , 2001, Blood.

[41]  G. Ehninger,et al.  Analysis of FLT3-activating mutations in 979 patients with acute myelogenous leukemia: association with FAB subtypes and identification of subgroups with poor prognosis. , 2002, Blood.